164 related articles for article (PubMed ID: 36376460)
1. Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer.
Le UQ; Chen N; Balasenthil S; Lurie E; Yang F; Liu S; Rubin L; Solis Soto LM; Raso MG; Batra H; Sahin AA; Wistuba II; Killary AM
Sci Rep; 2022 Nov; 12(1):19504. PubMed ID: 36376460
[TBL] [Abstract][Full Text] [Related]
2. DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.
Chen N; Balasenthil S; Reuther J; Frayna A; Wang Y; Chandler DS; Abruzzo LV; Rashid A; Rodriguez J; Lozano G; Cao Y; Lokken E; Chen J; Frazier ML; Sahin AA; Wistuba II; Sen S; Lott ST; Killary AM
Cancer Discov; 2013 Oct; 3(10):1172-89. PubMed ID: 23838884
[TBL] [Abstract][Full Text] [Related]
3. DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.
Lott ST; Chen N; Chandler DS; Yang Q; Wang L; Rodriguez M; Xie H; Balasenthil S; Buchholz TA; Sahin AA; Chaung K; Zhang B; Olufemi SE; Chen J; Adams H; Band V; El-Naggar AK; Frazier ML; Keyomarsi K; Hunt KK; Sen S; Haffty B; Hewitt SM; Krahe R; Killary AM
PLoS Med; 2009 May; 6(5):e1000068. PubMed ID: 19536326
[TBL] [Abstract][Full Text] [Related]
4. DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity.
Chen N; Balasenthil S; Reuther J; Killary AM
Cancer Res; 2014 Oct; 74(20):5683-9. PubMed ID: 25261235
[TBL] [Abstract][Full Text] [Related]
5. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
6. Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
Sarrio D; Franklin CK; Mackay A; Reis-Filho JS; Isacke CM
Stem Cells; 2012 Feb; 30(2):292-303. PubMed ID: 22102611
[TBL] [Abstract][Full Text] [Related]
7. Slug controls stem/progenitor cell growth dynamics during mammary gland morphogenesis.
Nassour M; Idoux-Gillet Y; Selmi A; Côme C; Faraldo ML; Deugnier MA; Savagner P
PLoS One; 2012; 7(12):e53498. PubMed ID: 23300933
[TBL] [Abstract][Full Text] [Related]
8. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
9. ΔNp63 regulates cell proliferation, differentiation, adhesion, and migration in the BL2 subtype of basal-like breast cancer.
Orzol P; Nekulova M; Holcakova J; Muller P; Votesek B; Coates PJ
Tumour Biol; 2016 Aug; 37(8):10133-40. PubMed ID: 26825981
[TBL] [Abstract][Full Text] [Related]
10. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
[No Abstract] [Full Text] [Related]
11. Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade.
Kumar B; Prasad M; Bhat-Nakshatri P; Anjanappa M; Kalra M; Marino N; Storniolo AM; Rao X; Liu S; Wan J; Liu Y; Nakshatri H
Cancer Res; 2018 Sep; 78(17):5107-5123. PubMed ID: 29997232
[TBL] [Abstract][Full Text] [Related]
12. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.
Parvani JG; Davuluri G; Wendt MK; Espinosa C; Tian M; Danielpour D; Sossey-Alaoui K; Schiemann WP
Neoplasia; 2015 Mar; 17(3):317-28. PubMed ID: 25810016
[TBL] [Abstract][Full Text] [Related]
13. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
15. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
16. Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
Bonetti P; Climent M; Panebianco F; Tordonato C; Santoro A; Marzi MJ; Pelicci PG; Ventura A; Nicassio F
Oncogene; 2019 Jan; 38(3):360-374. PubMed ID: 30093634
[TBL] [Abstract][Full Text] [Related]
17. Mouse mammary stem cells express prognostic markers for triple-negative breast cancer.
Soady KJ; Kendrick H; Gao Q; Tutt A; Zvelebil M; Ordonez LD; Quist J; Tan DW; Isacke CM; Grigoriadis A; Smalley MJ
Breast Cancer Res; 2015 Mar; 17(1):31. PubMed ID: 25849541
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.
Pomp V; Leo C; Mauracher A; Korol D; Guo W; Varga Z
Breast Cancer Res Treat; 2015 Nov; 154(1):45-55. PubMed ID: 26467042
[TBL] [Abstract][Full Text] [Related]
19. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Lo PK; Lee JS; Liang X; Sukumar S
Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
[TBL] [Abstract][Full Text] [Related]
20. Dual TGFβ/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast.
Prasad M; Kumar B; Bhat-Nakshatri P; Anjanappa M; Sandusky G; Miller KD; Storniolo AM; Nakshatri H
Mol Cancer Res; 2019 Jul; 17(7):1556-1570. PubMed ID: 30992305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
